MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI), the Men's Health Biotech Company, announced that it will host a conference call and webcast tomorrow, December 8, 2006, at 9:00 a.m. Eastern Time to discuss results of the ostarine Phase II proof of concept clinical trial and to provide an update on its SARM program. GTx will issue a press release announcing the clinical trial results and SARM program update before the call.
